News

hand pouring sweetener into coffee

Top Diabetes News of Today

BY LAUREN CAHN: Trying to lose weight? Think about steering clear of “diet” foods sweetened with artificial sweeteners like sucralose: Not only are you setting yourself up for failure—check out how diet soda can make you fat—but new researchfrom George Washington University suggests you’re also putting yourself at risk for metabolic syndrome, a precursor to diabetes and heart disease.

Metabolic syndrome is a scary cluster of conditions that include high blood pressure, high blood sugar, unhealthy cholesterol levels, and abdominal fat. Each condition is bad enough on its own, but when you have at least three of them, you’re looking at twice the risk of heart disease and three to five times the risk of diabetes. And if you’re already battling obesity, the risk is even higher, warns senior study author, Sabyasachi Sen, MD, an associate professor of medicine at George Washington University and author of the research (which was presented at the annual meeting of the Endocrine Society). (read more)

Breastfeeding For 6 Months Can Help Reduce Diabetes Risk

BY SIVA SRINU: Breastfeeding For 6 Months Can Help Reduce Diabetes Risk:-According to a research, females that nursed for 6 months or even more have nearly half the danger of kind 2 diabetic issues throughout their childbearing years. The research study disclosed a substantial organization in between period of breastfeeding and also lowered danger of diabetic issues, after all various other feasible danger aspects were represented. Females nursing for 6 months or longer nevertheless births had a 47% lowered danger of kind 2 diabetic issues in contrast to females not nursing whatsoever. Those nursing for 6 months or much less had a 25% lowered risk of diabetic issues. Information was assessed from the CARDIA study 30 year subsequent. (read more)

Anti-Diabetic Drug Linked with Inflammatory Bowel Disease, Heart Failure, and Joint Pain

BY DEVON ANDRE: Inflammatory bowel disease (IBS) has recently been linked to the use of an anti-diabetic drug known as dipeptidyl peptidase-4 inhibitors in a new study released recently. According to the researchers, the increased risk of IBS associated with the drugs was relatively low and their research needs to be replicated before the results can be verified.

The use of dipeptidyl peptidase-4 inhibitors to treat type 2 diabetes is a recently developed practice and the effects of the drugs are not fully known. They work by inhibiting the DPP-4, which plays a role in the regulation of gut hormones as well as inflammatory response. Understandably, the researchers found a slightly increased risk of developing IBS in type 2 diabetes patients, considering IBS is known for causing inflammation in the gastrointestinal system as well as bloating and pain in the stomach. (read more)

Diabetes cases are increasing in U.S.

BY AMY STONE: The number of cases of Diabetes in the United States continues to increase, but for many People, the Disease can be prevented or controlled.

People with diabetes have high Blood glucose levels because their pancreases do not produce enough hormone Insulin, or those that produce insulin are not effective.

It is an old condition that can be successfully fought by induced Patients to make healthy changes in their lives.

Type 2 Diabetes is by and large analyzed in grown-ups who are hefty or who have a family history of the disease. For those patients, the pancreas does not deliver enough insulin to deal with the measure of Sugar in their frameworks. (read more)

Abbott invests in diabetes care start-up

BY ANGELICA LAVITO: Abbott is taking its partnership with a diabetes care start-up one step further.

The health-care company hsa invested an undisclosed amount in Bigfoot Biomedical, a start-up creating diabetes care devices and systems. Bigfoot said Wednesday it has raised $55 million in Series B financing, bringing its total funding to $90 million.

The funds will help Bigfoot build a diabetes platform that will offer everything but the insulin, said CEO Jeffrey Brewer. Bigfoot plans to develop insulin pens, pumps and glucose monitors and connect them with smartphone technology. It also plans to prescribe them together and have them reimbursed as a monthly fee. (read more)